U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07038044) titled 'Safety and Efficacy of an Arginine-Restricted Diet in Patients With Solid Tumors' on April 15.
Brief Summary: This is a phase I single-arm clinical study conducted by West China Hospital of Sichuan University. The research duration is from March 2025 to March 2027, aiming to evaluate the safety and efficacy of arginine-restricted diet (-Arg diet) in patients with solid tumors. A total of 25 patients with solid tumors, aged 18 - 75 years old, who meet specific inclusion criteria such as having at least one measurable lesion according to RECIST v1.1 criteria and an ECOG score of 0 - 1, will be enrolled.
Patients will receive -Arg die...